Shufro Rose & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Sell |
37,011
-701
| -2% | -$250K | 0.89% | 32 |
|
|
2025
Q4 | $12.3M | Buy |
37,712
+672
| +2% | +$213K | 0.83% | 34 |
|
|
2025
Q3 | $11.5M | Sell |
37,040
-1,403
| -4% | -$407K | 0.94% | 27 |
|
|
2025
Q2 | $12M | Sell |
38,443
-1,248
| -3% | -$354K | 0.96% | 28 |
|
|
2025
Q1 | $12.4M | Sell |
39,691
-741
| -2% | -$219K | 0.98% | 28 |
|
|
2024
Q4 | $10.5M | Sell |
40,432
-1,304
| -3% | -$387K | 0.81% | 33 |
|
|
2024
Q3 | $13M | Hold |
41,736
| – | – | 1.06% | 26 |
|
|
2024
Q2 | $13M | Sell |
41,736
-400
| -0.9% | -$118K | 1.06% | 26 |
|
|
2024
Q1 | $12M | Sell |
42,136
-123
| -0.3% | -$36K | 0.99% | 28 |
|
|
2023
Q4 | $11.4M | Sell |
42,259
-477
| -1% | -$130K | 1.08% | 27 |
|
|
2023
Q3 | $11.5M | Sell |
42,736
-213
| -0.5% | -$53.2K | 1.08% | 27 |
|
|
2023
Q2 | $9.54M | Sell |
42,949
-838
| -2% | -$194K | 0.87% | 34 |
|
|
2023
Q1 | $10.6M | Sell |
43,787
-1,426
| -3% | -$350K | 0.98% | 29 |
|
|
2022
Q4 | $11.9M | Sell |
45,213
-2,475
| -5% | -$663K | 1% | 29 |
|
|
2022
Q3 | $10.7M | Sell |
47,688
-17
| -0% | -$4.12K | 1.07% | 28 |
|
|
2022
Q2 | $11.6M | Buy |
47,705
+27
| +0.1% | +$6.62K | 1.01% | 29 |
|
|
2022
Q1 | $11.5M | Sell |
47,678
-1,452
| -3% | -$334K | 0.89% | 33 |
|
|
2021
Q4 | $11.1M | Sell |
49,130
-1,732
| -3% | -$366K | 0.8% | 38 |
|
|
2021
Q3 | $10.8M | Sell |
50,862
-1,437
| -3% | -$331K | 0.85% | 34 |
|
|
2021
Q2 | $12.7M | Sell |
52,299
-490
| -0.9% | -$121K | 0.96% | 31 |
|
|
2021
Q1 | $13.1M | Sell |
52,789
-375
| -0.7% | -$89.5K | 1.04% | 27 |
|
|
2020
Q4 | $12.2M | Sell |
53,164
-8,832
| -14% | -$2.04M | 1.02% | 30 |
|
|
2020
Q3 | $15.8M | Sell |
61,996
-1,173
| -2% | -$291K | 1.52% | 23 |
|
|
2020
Q2 | $14.9M | Sell |
63,169
-17,885
| -22% | -$4.08M | 1.47% | 23 |
|
|
2020
Q1 | $16.4M | Sell |
81,054
-9,086
| -10% | -$1.98M | 1.96% | 15 |
|
|
2019
Q4 | $21.7M | Sell |
90,140
-1,626
| -2% | -$358K | 1.96% | 14 |
|
|
2019
Q3 | $17.8M | Sell |
91,766
-1,019
| -1% | -$196K | 1.76% | 16 |
|
|
2019
Q2 | $17.1M | Buy |
92,785
+12,885
| +16% | +$2.31M | 1.66% | 20 |
|
|
2019
Q1 | $15.2M | Sell |
79,900
-1,677
| -2% | -$320K | 1.52% | 21 |
|
|
2018
Q4 | $15.9M | Sell |
81,577
-1,486
| -2% | -$290K | 1.76% | 16 |
|
|
2018
Q3 | $17.2M | Sell |
83,063
-1,348
| -2% | -$266K | 1.6% | 16 |
|
|
2018
Q2 | $15.6M | Sell |
84,411
-746
| -0.9% | -$132K | 1.49% | 20 |
|
|
2018
Q1 | $14.5M | Sell |
85,157
-14,506
| -15% | -$2.66M | 1.43% | 21 |
|
|
2017
Q4 | $17.3M | Sell |
99,663
-343
| -0.3% | -$60.7K | 1.71% | 17 |
|
|
2017
Q3 | $18.6M | Sell |
100,006
-1,085
| -1% | -$192K | 1.87% | 13 |
|
|
2017
Q2 | $17.4M | Sell |
101,091
-1,315
| -1% | -$214K | 1.86% | 14 |
|
|
2017
Q1 | $16.8M | Sell |
102,406
-3,435
| -3% | -$571K | 1.81% | 13 |
|
|
2016
Q4 | $15.5M | Sell |
105,841
-116
| -0.1% | -$17.5K | 1.73% | 15 |
|
|
2016
Q3 | $17.7M | Sell |
105,957
-4,243
| -4% | -$718K | 1.98% | 10 |
|
|
2016
Q2 | $16.8M | Sell |
110,200
-4,770
| -4% | -$742K | 1.85% | 13 |
|
|
2016
Q1 | $17.2M | Sell |
114,970
-1,369
| -1% | -$203K | 1.93% | 10 |
|
|
2015
Q4 | $18.9M | Sell |
116,339
-924
| -0.8% | -$145K | 2.17% | 10 |
|
|
2015
Q3 | $16.2M | Sell |
117,263
-2,625
| -2% | -$414K | 1.95% | 10 |
|
|
2015
Q2 | $18.4M | Sell |
119,888
-6,880
| -5% | -$1.1M | 1.96% | 13 |
|
|
2015
Q1 | $20.3M | Sell |
126,768
-5,925
| -4% | -$933K | 2.08% | 10 |
|
|
2014
Q4 | $21.1M | Sell |
132,693
-1,100
| -0.8% | -$171K | 2.15% | 9 |
|
|
2014
Q3 | $18.8M | Sell |
133,793
-4,259
| -3% | -$556K | 1.95% | 10 |
|
|
2014
Q2 | $16.3M | Sell |
138,052
-3,160
| -2% | -$366K | 1.68% | 15 |
|
|
2014
Q1 | $17.4M | Sell |
141,212
-2,780
| -2% | -$337K | 1.82% | 13 |
|
|
2013
Q4 | $16.4M | Buy |
143,992
+1,340
| +0.9% | +$152K | 1.73% | 14 |
|
|
2013
Q3 | $16M | Sell |
142,652
-5,145
| -3% | -$558K | 1.82% | 15 |
|
|
2013
Q2 | $14.6M | Buy |
+147,797
| New | +$15.3M | 1.73% | 14 |
|
Other funds holding AMGN
VCM
VPM
Shufro Rose & Co's AMGN Position: Q1 2026 in Review
Shufro Rose & Co reduced its Amgen (AMGN) stake by 1.9% in Q1 2026, selling an estimated $250K and leaving 37,011 shares worth $13M. The position accounts for 0.89% of the portfolio, ranked #32.
Shufro Rose & Co first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.7M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Shufro Rose & Co held 37,011 shares of Amgen worth $13M as of Q1 2026.
- Shufro Rose & Co sold 701 Amgen shares in Q1 2026, an estimated $250K.
- Amgen made up 0.89% of Shufro Rose & Co's portfolio in Q1 2026, its #32 holding.
- Shufro Rose & Co first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Shufro Rose & Co's Amgen position peaked at $21.7M in Q4 2019.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.